(Q33953931)

English

Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study

scientific article

Statements

Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study (English)
Juan Gomez-Reino
Patrick Durez
Andre Beaulieu
Anthony Sebba
Gerhard Krammer
Ralph Preiss
Udayasankar Arulmani
Albert Widmer
Xavier Gitton
Herbert Kellner

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit